Cannabinoid hyperemesis syndrome prevalence and risk factors in the U.S․

Nicholas C. Glodosky, Sarah A. Okey, Tyler D. Watson, David Hammond

Open source

DOI: 10.1016/j.drugpo.2026.105307
Published: 2026-07
Container: International Journal of Drug Policy
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.drugpo.2026.105307,
  title = {Cannabinoid hyperemesis syndrome prevalence and risk factors in the U.S․},
  author = {Nicholas C. Glodosky and Sarah A. Okey and Tyler D. Watson and David Hammond},
  year = {2026},
  journal = {International Journal of Drug Policy},
  doi = {10.1016/j.drugpo.2026.105307},
  url = {https://doi.org/10.1016/j.drugpo.2026.105307}
}

RIS

TY  - JOUR
TI  - Cannabinoid hyperemesis syndrome prevalence and risk factors in the U.S․
AU  - Nicholas C. Glodosky
AU  - Sarah A. Okey
AU  - Tyler D. Watson
AU  - David Hammond
PY  - 2026
JO  - International Journal of Drug Policy
DO  - 10.1016/j.drugpo.2026.105307
UR  - https://doi.org/10.1016/j.drugpo.2026.105307
ER  -

APA

Glodosky, N. C., Okey, S. A., Watson, T. D., & Hammond, D. (2026). Cannabinoid hyperemesis syndrome prevalence and risk factors in the U.S․. International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2026.105307

Source records

crossref · retrieved 2026-09-27T00:06:33.622Z